Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
133.6 USD | -1.03% | -3.44% | +2.54% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.54% | 13.58B | |
+17.97% | 125B | |
+13.35% | 108B | |
-6.19% | 24.21B | |
+0.17% | 22.78B | |
-10.90% | 17.96B | |
-41.74% | 16.43B | |
-13.98% | 16.37B | |
+28.57% | 11.66B | |
+81.99% | 9.17B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Oppenheimer Adjusts Neurocrine Biosciences Price Target to $216 From $200, Maintains Outperform Rating